The drug, lecanemab, made by Eisai and Biogen, also carried risks of brain swelling and bleeding and should be studied further, a report of the findings said.
from NYT > U.S. News https://ift.tt/BnV5mk6
via IFTTT
Hot Posts
4/footer/recent
Search This Blog
Most Recent
Design by - Free Blogger Templates | Distributed by Blogger Templates